Interaction Effect of Psoriasis and Cancer on the Risk of All-Cause Mortality: A Prospective Cohort Study of NHANES Data

Overview

Journal Indian J Dermatol

Specialty Dermatology

Date 2024 Sep 19

PMID 39296686

Authors

Zixiang Si

Honglei Zhao

Jieya Ying

Affiliations

Soon will be listed here.

Abstract

Background: The relationship between psoriasis, cancer, and mortality has been reported in observational studies. Considering the high heterogeneity in systematic review and meta-analysis and inconsistent results in previous studies, the association between psoriasis, cancer, and mortality warrants more investigation. The primary objective of this study was to explore the joint impact of psoriasis and cancer on mortality in a representative cohort of adults residing in the United States.

Methods: We analysed comprehensive data obtained from the National Health and Nutrition Examination Study conducted during the periods of 2003-2006 and 2009-2014. Multivariable logistic regression analyses were performed to assess the relationship between psoriasis and cancer. The vital status of participants was tracked until 31 December 2019. A four-level variable combining information on psoriasis and cancer was created, and survival probability was evaluated using the Kaplan-Meier curve and Cox regression analysis. Hazard ratios (HRs) and their corresponding 95% confidence intervals (CIs) were calculated to analyse the association between psoriasis/cancer and all-cause mortality.

Results: In total, this study included 15,234 participants, among whom 418 had psoriasis and 1213 had cancer. The findings from the logistic regression analyses indicated a heightened risk of cancer among individuals with psoriasis in comparison to those without psoriasis. Moreover, the risk of skin cancer was higher in participants with psoriasis compared to those without psoriasis. Compared with individuals without cancer and psoriasis, the all-cause mortality HRs were 1.25 (95% CI: 0.87-1.78) for individuals with psoriasis only, 1.48 (95% CI: 1.20-1.82) for participants with cancer only, and 2.28 (95% CI: 1.12-4.63) for individuals with both psoriasis and cancer.

Conclusion: The results of our study demonstrated a noteworthy and positive correlation between psoriasis, cancer, and all-cause mortality. These findings indicate that individuals who have both psoriasis and cancer face an increased likelihood of mortality.

References

Yang Z, Lin N, Li L, Li Y . The Effect of TNF Inhibitors on Cardiovascular Events in Psoriasis and Psoriatic Arthritis: an Updated Meta-Analysis. Clin Rev Allergy Immunol. 2016; 51(2):240-7. DOI: 10.1007/s12016-016-8560-9. View

Balda A, Wani I, Roohi T, Suman , Krishna K, Mehdi S . Psoriasis and skin cancer - Is there a link?. Int Immunopharmacol. 2023; 121:110464. DOI: 10.1016/j.intimp.2023.110464. View

Lee J, Kim H, Han K, Kim H, Park Y, Lee J . Cancer risk in 892 089 patients with psoriasis in Korea: A nationwide population-based cohort study. J Dermatol. 2018; 46(2):95-102. DOI: 10.1111/1346-8138.14698. View

Cathey A, Nguyen V, Colacino J, Woodruff T, Reynolds P, Aung M . Exploratory profiles of phenols, parabens, and per- and poly-fluoroalkyl substances among NHANES study participants in association with previous cancer diagnoses. J Expo Sci Environ Epidemiol. 2023; 33(5):687-698. PMC: 10541322. DOI: 10.1038/s41370-023-00601-6. View

Trafford A, Parisi R, Kontopantelis E, Griffiths C, Ashcroft D . Association of Psoriasis With the Risk of Developing or Dying of Cancer: A Systematic Review and Meta-analysis. JAMA Dermatol. 2019; 155(12):1390-1403. PMC: 6802036. DOI: 10.1001/jamadermatol.2019.3056. View

Costache D, Bejan H, Poenaru M, Costache R . Skin Cancer Correlations in Psoriatic Patients. Cancers (Basel). 2023; 15(9). PMC: 10177598. DOI: 10.3390/cancers15092451. View

Gelfand J, Troxel A, Lewis J, Kurd S, Shin D, Wang X . The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol. 2007; 143(12):1493-9. DOI: 10.1001/archderm.143.12.1493. View

Chen T, Clark J, Riddles M, Mohadjer L, Fakhouri T . National Health and Nutrition Examination Survey, 2015-2018: Sample Design and Estimation Procedures. Vital Health Stat 2. 2021; (184):1-35. View

Rahman H, Toohey W, Munson-McGee S . Exposure to arsenic, polycyclic aromatic hydrocarbons, metals, and association with skin cancers in the US adults. Environ Sci Pollut Res Int. 2023; 30(45):101681-101708. DOI: 10.1007/s11356-023-29422-8. View

10.

Miller K, Nogueira L, Devasia T, Mariotto A, Yabroff K, Jemal A . Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022; 72(5):409-436. DOI: 10.3322/caac.21731. View

11.

Springate D, Parisi R, Kontopantelis E, Reeves D, Griffiths C, Ashcroft D . Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort study. Br J Dermatol. 2016; 176(3):650-658. PMC: 5363241. DOI: 10.1111/bjd.15021. View

12.

Yu N, Wang J, Liu Y, Guo Y . Multivariate Mendelian randomization provides no evidence for causal associations among both psoriasis and psoriatic arthritis, and skin cancer. Front Immunol. 2023; 14:1252720. PMC: 10546308. DOI: 10.3389/fimmu.2023.1252720. View

13.

Deighton C, Hyrich K . International guidelines on access to biologic therapy: why the differences and which is best?. Nat Clin Pract Rheumatol. 2008; 4(10):520-1. DOI: 10.1038/ncprheum0877. View

14.

Paradisi A, Didona B, Tabolli S, Ricci F, Sobrino L, Panebianco A . Reduced frequency of non-melanoma skin cancer in 72,739 patients with psoriasis: a retrospective study. Eur J Dermatol. 2017; 27(4):359-362. DOI: 10.1684/ejd.2017.3032. View

15.

Tseng H, Lin H, Lam H . Co-morbidities in psoriasis: a hospital-based case-control study. J Eur Acad Dermatol Venereol. 2012; 27(11):1417-25. DOI: 10.1111/jdv.12028. View

16.

Loft N, Vaengebjerg S, Skov L . Cancer risk in patients with psoriasis: should we be paying more attention?. Expert Rev Clin Immunol. 2020; 16(5):479-492. DOI: 10.1080/1744666X.2020.1754194. View

17.

Holland L, Bradford N, Youl P, Cossio D, Dunn N, Tran N . Cancer Incidence, Mortality, and Survival for Children, Adolescents, and Young Adults in Queensland Between 1987 and 2016. J Adolesc Young Adult Oncol. 2020; 10(6):629-644. DOI: 10.1089/jayao.2020.0151. View

18.

Dhana A, Yen H, Yen H, Cho E . All-cause and cause-specific mortality in psoriasis: A systematic review and meta-analysis. J Am Acad Dermatol. 2018; 80(5):1332-1343. DOI: 10.1016/j.jaad.2018.12.037. View

19.

Semenov Y, Herbosa C, Rogers A, Huang A, Kwatra S, Cohen B . Psoriasis and mortality in the United States: Data from the National Health and Nutrition Examination Survey. J Am Acad Dermatol. 2019; 85(2):396-403. DOI: 10.1016/j.jaad.2019.08.011. View

20.

Armstrong A, Read C . Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review. JAMA. 2020; 323(19):1945-1960. DOI: 10.1001/jama.2020.4006. View